SEC Form 4 · accession 0001127602-16-038844
ILLUMINA, INC. · ILMN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Tristan Orpin
Officer — EVP Clinical Genomics
Period of report
Jan 29, 2016
Accepted (ET)
Feb 1, 2016 · 8:24 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001110803
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 29, 2016 | F | 529 | $157.95 | D | 102,062 | D | |
| Common Stock | Jan 29, 2016 | F | 265 | $157.95 | D | 101,797 | D |
Table II — derivative securities
No Table II lines on this filing.